Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developing DANYELZA that is in Phase II clinical studies for the treatment of patients with first-line neuroblastoma, third-line neuroblastoma, and in relapsed osteosarcoma; GD2-GD3 vaccine that is in Phase II clinical trial for the treatment of Stage 4 high-risk neuroblastoma; and Omburtamab, a murine monoclonal antibody that is in clinical trials for the treatment of central nervous system/ leptomeningeal metastases from neuroblastoma, desmoplastic small round cell tumor, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. In addition, it is developing Nivatrotamab for the treatment of small cell lung cancer, as well as is in Phase I/II trial for the treatment of refractory GD2 positive adult and pediatric solid tumors; and Lu-omburtamab-DTPA that is in Phase I clinical development for the treatment of medulloblastoma and B7-H3 positive leptomeningeal metastases from solid tumors. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Y-mAbs Therapeutics Inc..
Y-mAbs Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Y-mAbs Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Y-mAbs Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Y-mAbs Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Y-mAbs Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Y-mAbs Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Y-mAbs Therapeutics Inc.- Key Facts
2.2 Y-mAbs Therapeutics Inc.- Geographic Locations
2.3 Y-mAbs Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Y-mAbs Therapeutics Inc.- Business Divisions
2.5 Y-mAbs Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Y-mAbs Therapeutics Inc. Strategic Analysis Review
3.1 Y-mAbs Therapeutics Inc.- Key Strategies
3.2 Y-mAbs Therapeutics Inc.- Company Outlook Statement
3.3 Y-mAbs Therapeutics Inc.- SWOT Analysis
3.3.1 Y-mAbs Therapeutics Inc.- Key Strengths
3.3.2 Y-mAbs Therapeutics Inc.- Key Weaknesses
3.3.3 Y-mAbs Therapeutics Inc.- Potential Opportunities
3.3.4 Y-mAbs Therapeutics Inc.- Potential Threats
3.4 Y-mAbs Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Y-mAbs Therapeutics Inc.- Business Overview
4.2 Y-mAbs Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Y-mAbs Therapeutics Inc.- Key Products
5.2 Y-mAbs Therapeutics Inc.- Key Service Areas
5.3 Y-mAbs Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Y-mAbs Therapeutics Inc.- Company History
6.2 Y-mAbs Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Y-mAbs Therapeutics Inc.- Income Statements
7.2 Y-mAbs Therapeutics Inc.- Balance Sheet
7.3 Y-mAbs Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Y-mAbs Therapeutics Inc.- Direct Competitors
8.2 Y-mAbs Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Y-mAbs Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Y-mAbs Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$50- 10%
$100- 20%
$200- 10%
$100- 20%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
